The European companion diagnostics market is booming, projected to reach €2.7 billion by 2033 with a 9.23% CAGR. Driven by personalized medicine, advanced technologies like gene sequencing, and rising cancer rates, this market offers lucrative opportunities. Learn about key players, market segments (IHC, PCR, etc.), and regional trends in Europe.
We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.